↓ Skip to main content

Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma

Overview of attention for article published in Journal for Immunotherapy of Cancer, October 2023
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#26 of 3,451)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
48 news outlets
twitter
8 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
7 Mendeley